{
    "ticker": "OGN",
    "name": "Organon & Co.",
    "description": "Organon & Co. is a global healthcare company dedicated to improving the health of women throughout their lives. Founded in 2021 as a spin-off from Merck & Co., Organon focuses on addressing the unmet healthcare needs of women across various stages of life, from reproductive health to menopause and beyond. The company offers a wide range of products, including contraceptives, hormone replacement therapies, and medications for various health conditions affecting women. With a commitment to advancing women's health, Organon invests in research and development to create innovative solutions that empower women to take control of their health. The company aims to provide access to essential healthcare products and services, particularly in underserved communities. Organon operates in over 140 countries, bringing together diverse teams of experts to address challenges in women's health and improve patient outcomes. Through strategic partnerships and collaborations, Organon seeks to enhance its product offerings and expand its global reach. The company\u2019s mission is to ensure that every woman has the opportunity to live her best life through quality healthcare and support.",
    "industry": [
        "Pharmaceuticals",
        "Healthcare"
    ],
    "headquarters": "Hoboken, New Jersey, USA",
    "founded": "2021",
    "website": "https://www.organon.com",
    "ceo": "Kevin Ali",
    "social_media": {
        "twitter": "https://twitter.com/Organon",
        "linkedin": "https://www.linkedin.com/company/organon/"
    },
    "investor_relations": "https://investors.organon.com",
    "key_executives": [
        {
            "name": "Kevin Ali",
            "position": "CEO"
        },
        {
            "name": "Dawn D. H. O'Connell",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Reproductive Health",
            "products": [
                "Contraceptives",
                "Fertility Treatments"
            ]
        },
        {
            "category": "Menopause",
            "products": [
                "Hormone Replacement Therapy"
            ]
        },
        {
            "category": "Chronic Conditions",
            "products": [
                "Medications for various health conditions"
            ]
        }
    ],
    "seo": {
        "meta_title": "Organon & Co. | Women's Health and Healthcare Solutions",
        "meta_description": "Explore Organon & Co., a global healthcare company focused on improving women's health through innovative products and services. Learn more about Organon\u2019s commitment to empowering women.",
        "keywords": [
            "Organon",
            "Women's Health",
            "Reproductive Health",
            "Menopause",
            "Healthcare Solutions"
        ]
    },
    "faq": [
        {
            "question": "What is Organon known for?",
            "answer": "Organon is known for its commitment to women's health, offering a range of healthcare products and solutions for women throughout their lives."
        },
        {
            "question": "Who is the CEO of Organon?",
            "answer": "Kevin Ali is the CEO of Organon & Co."
        },
        {
            "question": "Where is Organon headquartered?",
            "answer": "Organon is headquartered in Hoboken, New Jersey, USA."
        },
        {
            "question": "What products does Organon offer?",
            "answer": "Organon offers products related to reproductive health, menopause, and chronic conditions affecting women."
        },
        {
            "question": "When was Organon founded?",
            "answer": "Organon was founded in 2021."
        }
    ],
    "competitors": [
        "PFE",
        "JNJ",
        "ABBV",
        "BMY"
    ],
    "related_stocks": [
        "MRK",
        "AMGN",
        "GILD",
        "NVS"
    ]
}